These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17988560)

  • 1. [Molecular and biological research on respiratory muscle wasting in chronic obstructive pulmonary disease].
    Ju CR; Chen RC
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Aug; 30(8):613-5. PubMed ID: 17988560
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum myostatin levels and skeletal muscle wasting in chronic obstructive pulmonary disease.
    Ju CR; Chen RC
    Respir Med; 2012 Jan; 106(1):102-8. PubMed ID: 21840694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease.
    Langen RC; Gosker HR; Remels AH; Schols AM
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2245-56. PubMed ID: 23827718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic inflammation and skeletal muscle dysfunction in chronic obstructive pulmonary disease: state of the art and novel insights in regulation of muscle plasticity.
    Remels AH; Gosker HR; van der Velden J; Langen RC; Schols AM
    Clin Chest Med; 2007 Sep; 28(3):537-52, vi. PubMed ID: 17720042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitination and proteolysis in limb and respiratory muscles of patients with chronic obstructive pulmonary disease.
    Debigaré R; Côté CH; Maltais F
    Proc Am Thorac Soc; 2010 Feb; 7(1):84-90. PubMed ID: 20160153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal muscle response to inflammation--lessons for chronic obstructive pulmonary disease.
    Reid WD; Rurak J; Harris RL
    Crit Care Med; 2009 Oct; 37(10 Suppl):S372-83. PubMed ID: 20046123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease.
    Kim HC; Mofarrahi M; Hussain SN
    Int J Chron Obstruct Pulmon Dis; 2008; 3(4):637-58. PubMed ID: 19281080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The possible role of myostatin in skeletal muscle atrophy and cachexia.
    Jespersen J; Kjaer M; Schjerling P
    Scand J Med Sci Sports; 2006 Apr; 16(2):74-82. PubMed ID: 16533345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of muscle size during disuse, disease, and aging.
    Degens H; Alway SE
    Int J Sports Med; 2006 Feb; 27(2):94-9. PubMed ID: 16475053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reduction of muscle mass mediated by myostatin in an experimental model of pulmonary emphysema].
    Fermoselle C; Sanchez F; Barreiro E
    Arch Bronconeumol; 2011 Dec; 47(12):590-8. PubMed ID: 22056524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative assessment of the quadriceps and the diaphragm in patients with COPD.
    Caron MA; Debigaré R; Dekhuijzen PN; Maltais F
    J Appl Physiol (1985); 2009 Sep; 107(3):952-61. PubMed ID: 19359618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting myostatin for therapies against muscle-wasting disorders.
    Tsuchida K
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):487-94. PubMed ID: 18600566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal muscles in chronic airflow obstruction: why bother?
    Maltais F
    Am J Respir Crit Care Med; 2003 Oct; 168(8):916-7. PubMed ID: 14555457
    [No Abstract]   [Full Text] [Related]  

  • 14. Myostatin and its precursor protein are increased in the skeletal muscle of patients with Type-II muscle fibre atrophy.
    Wójcik S; Nogalska A; Engel WK; Askanas V
    Folia Morphol (Warsz); 2008 Feb; 67(1):6-12. PubMed ID: 18335407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diaphragm and skeletal muscle dysfunction in COPD].
    Caron MA; Debigaré R; Dekhuijzen PN; Maltais F
    Rev Mal Respir; 2011 Dec; 28(10):1250-64. PubMed ID: 22152934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease. What We Know and Can Do for Our Patients.
    Jaitovich A; Barreiro E
    Am J Respir Crit Care Med; 2018 Jul; 198(2):175-186. PubMed ID: 29554438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness.
    Ryall JG; Schertzer JD; Lynch GS
    Biogerontology; 2008 Aug; 9(4):213-28. PubMed ID: 18299960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The "oil well analogy" as a comprehensive interpretation of factors leading to muscle injury and wasting.
    Orozco-Levi M; Lloreta J; Gea J
    Ultrastruct Pathol; 2006; 30(4):247-52. PubMed ID: 16971349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle wasting in cardiac cachexia.
    Strassburg S; Springer J; Anker SD
    Int J Biochem Cell Biol; 2005 Oct; 37(10):1938-47. PubMed ID: 15927519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MOTS-c reduces myostatin and muscle atrophy signaling.
    Kumagai H; Coelho AR; Wan J; Mehta HH; Yen K; Huang A; Zempo H; Fuku N; Maeda S; Oliveira PJ; Cohen P; Kim SJ
    Am J Physiol Endocrinol Metab; 2021 Apr; 320(4):E680-E690. PubMed ID: 33554779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.